During the last session, Nu Skin Enterprises, Inc. (NYSE:NUS)’s traded shares were 1.3 million, with the beta value of the company hitting 1.14. At the end of the trading day, the stock’s price was $7.32, reflecting an intraday gain of 1.53% or $0.11. The 52-week high for the NUS share is $24.16, that puts it down -230.05 from that peak though still a striking 8.2% gain since the share price plummeted to a 52-week low of $6.72. The company’s market capitalization is $363.80M, and the average intraday trading volume over the past 10 days was 1.17 million shares, and the average trade volume was 872.54K shares over the past three months.
Nu Skin Enterprises, Inc. (NYSE:NUS) trade information
Nu Skin Enterprises, Inc. (NUS) registered a 1.53% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 1.53% in intraday trading to $7.32, hitting a weekly high. The stock’s 5-day price performance is -3.94%, and it has moved by -24.92% in 30 days. Based on these gigs, the overall price performance for the year is -69.07%. The short interest in Nu Skin Enterprises, Inc. (NYSE:NUS) is 2.76 million shares and it means that shorts have 3.93 day(s) to cover.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The consensus price target of analysts on Wall Street is $11, which implies an increase of 33.45% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $11 and $11 respectively. As a result, NUS is trading at a discount of -50.27% off the target high and -50.27% off the low.
Nu Skin Enterprises, Inc. (NUS) estimates and forecasts
Statistics show that Nu Skin Enterprises, Inc. has underperformed its competitors in share price, compared to the industry in which it operates. Nu Skin Enterprises, Inc. (NUS) shares have gone down -41.95% during the last six months, with a year-to-date growth rate less than the industry average at -57.84% against 7.80. In the rating firms’ projections, revenue will decrease -10.90% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 440.57M as predicted by 3 analyst(s). Meanwhile, a consensus of 3 analyst(s) estimates revenue growth to 456.62M by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 520.09M and 488.64M respectively. In this case, analysts expect current quarter sales to shrink by -15.30% and then drop by -6.60% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -39.68%. While earnings are projected to return -57.72% in 2024, the next five years will return 6.81% per annum.
NUS Dividends
Nu Skin Enterprises, Inc. is due to release its next quarterly earnings in October. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance. Investors should also take the other fundamental and operational aspects into account before investing in the stock. The forward dividend ratio for Nu Skin Enterprises, Inc. is 0.57, with the dividend yield indicating at 7.79 percent, continuing the trend of increasing dividends in recent years. The average dividend yield of the company for the last 5 years is 4.64%.
Nu Skin Enterprises, Inc. (NYSE:NUS)’s Major holders
Nu Skin Enterprises, Inc. insiders own 2.26% of total outstanding shares while institutional holders control 87.17%, with the float percentage being 89.19%. BLACKROCK INC. is the largest shareholder of the company, while 282.0 institutions own stock in it. As of 2024-06-30, the company held over 8.12 million shares (or 16.3966% of all shares), a total value of $85.61 million in shares.
The next largest institutional holding, with 6.55 million shares, is of VANGUARD GROUP INC’s that is approximately 13.214% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $68.99 million.
